Increased Amyloid Precursor Protein and Tau Expression Manifests as Key Secondary Cell Death in Chronic Traumatic Brain Injury

Journal of Cellular Physiology

Volumn 232, Issue 3, 2017, Pages 665-677

  Acosta, Sandra A ^a   Tajiri, Naoki ^a   Sanberg, Paul R ^b   Kaneko, Yuji ^a   Borlongan, Cesar V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; EOSIN; HEMATOXYLIN; TAU PROTEIN; HLA ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN FORNIX; BRAIN TISSUE; CAPSULA INTERNA; CELL DEATH; CELL PROLIFERATION; CHRONIC BRAIN DISEASE; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; CYTOSOL; DENTATE GYRUS; DISEASE MARKER; FRONTAL CORTEX; GRAY MATTER; HEMISPHERE; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; INTERNEURON; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; NONHUMAN; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPRAGUE DAWLEY RAT; STAINING; SUBVENTRICULAR ZONE; THALAMUS; TRAUMATIC BRAIN INJURY; UPREGULATION; WHITE MATTER; ANIMAL; CHRONIC DISEASE; METABOLISM; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PATHOLOGY; PHOSPHORYLATION; PROTEIN MULTIMERIZATION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN INJURIES, TRAUMATIC; CELL DEATH; CELL PROLIFERATION; CHRONIC DISEASE; DENTATE GYRUS; GRAY MATTER; HISTOCOMPATIBILITY ANTIGENS CLASS II; NEUROGENESIS; NEURONS; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; RATS, SPRAGUE-DAWLEY; TAU PROTEINS; WHITE MATTER;

EID: 84991738734     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25629     Document Type: Article

References (71)

1. Abrahamson EE, Ikonomovic MD, Edward Dixon C, DeKosky ST. 2009. Simvastatin therapy prevents brain trauma-induced increases in β-amyloid peptide levels. Ann Neurol 66:407–414.
2. Acosta SA, Tajiri N, Shinozuka K, Ishikawa H, Grimmig B, David Diamond, Sanberg PR, Bickford PC, Kaneko Y, Borlongan CV. 2013. Long-term upregulation of inflammation and suppression of cell proliferation in the brain of adult rats exposed to traumatic brain injury using the controlled cortical impact model. PLoS ONE 8:e53376.
3. Acosta SA, Tajiri N, Shinozuka K, Ishikawa H, Sanberg PR, Sanchez-Ramos J, Song S, Kaneko Y, Borlongan CV. 2014. Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury. PLoS ONE 9:e90953.
4. Amaral DG, Witter MP. 1989. The three-dimensional organization of the hippocampal formation: A review of anatomical data. Neuroscience 31:571–591.
5. Aungst SL, Kabadi SV, Thompson SM, Stoica BA, Faden AI. 2014. Repeated mild traumatic brain injury causes chronic neuroinflammation, changes in hippocampal synaptic plasticity, and associated cognitive deficits. J Cereb Blood Flow Metab 34:1223–1232.
6. Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA, McLean AJ. 1994. Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 344:1055–1056.
7. Borgens RB, Liu-Snyder P. 2012. Understanding secondary injury. Q Rev Biol 87:89–127.
8. Chauhan NB. 2014. Chronic neurodegenerative consequences of traumatic brain injury. Restor Neurol Neurosci 32:337–365.
9. Chen Y, Liu W, McPhie DL, Hassinger L, Neve R. 2003. APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain. J Cell Biol 163:27–33.
10. Cho SH, Sun B, Zhou Y, Kauppinen TM, Halabisky B, Wes P, Ransohoff RM, Gan L. 2011. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem 286:32713–32722.
11. Dixon CE, Kochanek PM, Yan HQ, Schiding JK, Griffith RG, Baum E, Marion DW, DeKosky ST. 1999. One-year study of spatial memory performance, brain morphology, and cholinergic markers after moderate controlled cortical impact in rats. J Neurotrauma 16:109–122.
12. Elder GA. 2012. Blast exposure induces post-traumatic stress disorder-related traits in a rat model of mild traumatic brain injury. J Neurotrauma 29:2564–2575.
13. Fabrizio KS, Keltner NL. 2010. Traumatic brain injury in operation enduring freedom/operation iraqi freedom: A primer. Nurs Clin North Am 45:569–580.
14. Faul M, Xu L, Walt M, Coronado V. 2010. Traumatic brain injury in the United States: Emergency department visits, hospitalizations, and deaths, 2002–2006. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control.
15. Fleminger S, Oliver DL, Lovestone S, Rabe-Hesketh S, Giora A. 2003. Head injury as a risk factor for Alzheimer's disease: The evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry 74:857–862.
16. Gardner RC, Yaffe K. 2015. Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol Cell Neurosci 66:75–80.
17. Ge Y, Patel MB, Chen Q, Grossman EJ, Zhang K, Miles L, Babb JS, Reaume J, Grossman RI. 2009. Assessment of thalamic perfusion in patients with mild traumatic brain injury by true FISP arterial spin labelling MR imaging at 3T. Brain Inj 23:666–674.
18. Ghajar J. 2000. Traumatic brain injury. Lancet 356:923–929.
19. Glover LE, Tajiri N, Lau T, Kaneko Y, van Loveren H, Borlongan CV. 2012. Immediate, but not delayed, microsurgical skull reconstruction exacerbates brain damage in experimental traumatic brain injury model. PLoS ONE 7:e33646.
20. Gottlieb S. 2000. Head injury doubles the risk of Alzheimer's disease. BMJ 321:1100.
21. Hayward NM, Tuunanen PI, Immonen R, Ndode-Ekane XE, Pitkänen A, Gröhn O. 2011. Magnetic resonance imaging of regional hemodynamic and cerebrovascular recovery after lateral fluid-percussion brain injury in rats. J Cereb Blood Flow Metab 31:166–177.
22. Hayward NM, Immonen R, Tuunanen PI, Ndode-Ekane XE, Gröhn O, Pitkänen A. 2010. Association of chronic vascular changes with functional outcome after traumatic brain injury in rats. J Neurotrauma 27:2203–2219.
23. Haass C, Hung Y, Selkoe DJ. 1991. Processing of, β-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci 11:3783–3793.
24. He P, Zhong Z, Lindholm K, Berning L, Lee W, Lemere C, Staufenbiel M, Li R, Shen Y. 2007. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 178:829–841.
25. Hernandez-Ontiveros DG, Tajiri N, Acosta S, Giunta B, Tan J, Borlongan CV. 2013. Microglia activation as a biomarker for traumatic brain injury. Front Neurol 4:30.
26. Homsi S, Piaggio T, Croci N, Noble F, Plotkine M, Marchand-Leroux C, Jafarian-Tehrani M. 2010. Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: A twelve-week follow-up study. J Neurotrauma 27:911–921.
27. Hong YT, Veenith T, Dewar D, Outtrim JG, Mani V, Williams C, Pimlott S, Hutchinson PJ, Tavares A, Canales R, Mathis CA, Klunk WE, Aigbirhio FI, Coles JP, Baron JC, Pickard JD, Fryer TD, Stewart W, Menon DK. 2014. Amyloid imaging with carbon 11—Labeled pittsburgh compound B for traumatic brain injury. JAMA Neurol 71:23–31.
28. Hickman SE, Allison EK, El Khoury J. 2008. Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 28:8354–8360.
29. Hortobágyi T, Wise S, Hunt N, Cary N, Djurovic V, Fegan-Earl A, Shorrock K, Rouse D, Al-Sarraj S. 2007. Traumatic axonal damage in the brain can be detected using b-APP immunohistochemistry within 35min after head injury to human adults. Neuropathol Appl Neurobiol 33:226–237.
30. Iwata A, Chen XH, McIntosh TK, Browne KD, Smith DH. 2002. Long-term accumulation of amyloid-beta in axons following brain trauma without persistent upregulation of amyloid precursor protein genes. J Neuropathol Exp Neurol 61:1056–1068.
31. Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, Stewart W. 2013. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 136:28–42.
32. Johnson VE, Stewart W, Smith DH. 2012. Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol 22:142–149.
33. Kempermann G. 2002. Why new neurons? Possible functions for adult hippocampal neurogenesis. J Neurosci 22:635–638.
34. Little DM, Kraus MF, Joseph J, Geary EK, Susmaras T, Zhou XJ, Pliskin N, Gorelick PB. 2010. Thalamic integrity underlies executive dysfunction in traumatic brain injury. Neurology 74:558–564.
35. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. 2001. The curry spice curcumin reduces oxidative damage and amyloid pathology in an alzheimer transgenic mouse. J Neurosci 21:8370–8377.
36. Loane DJ, Byrnes KR. 2010. Role of microglia in neurotrauma. Neurotherapeutics 7:366–377.
37. Lozano D, Gonzales-Portillo GS, Acosta S, de la Pena I, Tajiri N, Kaneko Y, Borlongan CV. 2015. Neuroinflammatory responses to traumatic brain injury: Etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr Dis Treat 11:97–06.
38. Mannix RC, Whalen MJ. 2012. Traumatic brain injury, microglia, and Beta amyloid. Int J Alzheimers Dis 2012:608732.
39. Marshall SA, McClain JA, Kelso ML, Hopkins DM, Pauly JR, Nixon K. 2013. Microglial activation is not equivalent to neuroinflammation in alcohol-induced neurodegeneration: The importance of microglia phenotype. Neurobiol Dis 54:239–251.
40. Mayhew TM. 1991. The new stereological methods for interpreting functional morphology from slices of cells and organs. Exp Physiol 76:639–665.
41. McLaurin J, Almazan G, Williams K, Antel JP. 1995. Immortalization and characterization of rat microglial cells. Neuropathol Appl Neurobiol 21:302–311.
42. Mizuno T, Doi Y, Mizoguchi H, Jin S, Noda M, Sonobe Y, Takeuchi H, Suzumura A. 2011. Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity. Am J Pathol 179:2016–2027.
43. Murakami N, Yamaki T, Iwamoto Y, Sakakibara T, Kobori N, Fushiki S, Ueda S. 1998. Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J Neurotrauma 15:993–903.
44. Nakashiba T, Young JZ, McHugh TJ, Buhl DL, Tonegawa S. 2008. Transgenic inhibition of synaptictransmission reveals role of CA3 output in hippocampal learning. Science 319:1260–1264.
45. O'Keefe GM, Nguyen VT, Benveniste EN. 2002. Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases. J Neurovirol 8:496–512.
46. Park MS, Oh HA, Ko IG, Kim SE, Kim SH, Kim CJ, Kim HB, Kim H. 2014. Influence of mild traumatic brain injury during pediatric stage on short-term memory and hippocampal apoptosis in adult rats. J Exerc Rehabil 10:148–154.
47. Paxinos G, Watson C. 2005. The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press.
48. Phiel CJ, Wilson CA, Lee VM, Klein PS. 2003. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423:435–439.
49. Povlishock JT, Cristman CW. 1995. The pathobiology of traumatically induced axonal injury in animals and human: A review of current thoughts. J Neurotrauma 12:555–564.
50. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW. 1999. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30:77–105.
51. Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, Gentleman S, Heckemann RA, Gunanayagam K, Gelosa G, Sharp DJ. 2011. Inflammation after trauma: Microglial activation and traumatic brain injury. Ann Neurol 70:374–383.
52. Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U. 2010. Amyloid-beta and mitochondria in aging and Alzheimer's disease: Implications for synaptic damage and cognitive decline. J Alzheimers Dis 20:S499–S512.
53. Rogers JM, Read CA. 2007. Psychiatric comorbidity following traumatic brain injury. Brain Inj 21:1321–1333.
54. Rola R, Mizumatsu S, Otsuka S, Morhardt DR, Noble-Haeusslein LJ, Fishman K, Potts MB, Fike JR. 2006. Alterations in hippocampal neurogenesis following traumatic brain injury in mice. Exp Neurol 202:189–199.
55. Schiff ND. 2010. Recovery of consciousness after brain injury: A mesocircuit hypothesis. Trends Neurosci 33:1–9.
56. Schmidt OI, Heyde CE, Ertel W, Stahel PF. 2005. Closed head injury—An inflammatory disease? Brain Res Brain Res Rev 48:388–99.
57. Scholzen T, Gerdes J. 2000. The Ki-67 protein: From the known and the unknown. J Cell Physiol 182:311–322.
58. Scoville WG. 1954. The limbic lobe in man. J Neurosurg 11:64.
59. Selkoe DJ. 1997. Alzheimer's disease: Genotypes, phenotypes, and treatments. Science 275:630–631.
60. Sharp DJ, Scott G, Leech R. 2014. Network dysfunction after traumatic brain injury. Nat Rev Neurol 10:156–166.
61. Sheng JG, Bora SH, Xu G, Borchelt DR, Price DL, Koliatsos VE. 2003. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol Dis 14:133–45.
62. Soldatovic-Stajic B, Misic-Pavkov G, Bozic K, Novovic Z, Gajic Z. 2014. Neuropsychological and neurophysiological evaluation of cognitive deficits related to the severity of traumatic brain injury. Eur Rev Med Pharmacol Sci 18:1632–1637.
63. Strittmatter WJ, Roses AD. 1995. Apolipoprotein E and Alzheimer disease. PNAS 92911:4725.
64. Tajiri N, Kellogg SL, Shimizu T, Arendash GW, Borlongan CV. 2013. Traumatic brain injury precipitates cognitive impairment and extracellular Aβ aggregation in Alzheimer's disease transgenic mice. PLoS ONE 8:e8851.
65. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. 1999. Traumatic brain injury in the United States: A public health perspective. J Head Trauma Rehabil 14:602–615.
66. Uryu K, Chen XH, Martinez D, Browne KD, Johnson VE, Graham DI, Lee VM, Trojanowski JQ, Smith DH l. 2007. Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp Neurol 208:185–192.
67. Vasterling JJ, Brailey K, Proctor SP, Kane R, Heeren T, Franz M. 2012. Neuropsychological outcomes of mild traumatic brain injury, post-traumatic stress disorder and depression in Iraq-deployed US Army soldiers. Br J Psychiatry 201:186–192.
68. Wang GH, Jiang ZL, Li YC, Li X, Shi H, Gao YQ, Vosler PS, Chen J. 2011. Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats. J Neurotrauma 28:2123–2134.
69. Wang G, Jiang X, Pu H, Zhang W, An C, Hu X, Liou AK, Leak RK, Gao Y, Chen J. 2013. Scriptaid, a novel histone deacetylase inhibitor, protects against traumatic brain injury via modulation of PTEN and AKT pathway: Scriptaid protects against TBI via AKT. Neurotherapeutics 10:124–142.
70. Werner C, Engelhard K. 2007. Pathophysiology of traumatic brain injury. Br J Anaesth 99:4–9.
71. Zhao J, O'Connor T, Vassar R. 2011. The contribution of activated astrocytes to Abeta production: Implications for Alzheimer's disease pathogenesis. J Neuroinflammation 8:150.